{"id":358511,"date":"2025-08-29T20:49:22","date_gmt":"2025-08-29T20:49:22","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-disc-medicine\/"},"modified":"2025-08-29T20:49:22","modified_gmt":"2025-08-29T20:49:22","slug":"how-to-buy-disc-medicine","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/","title":{"rendered":"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334099,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-358511","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r - Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r - Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Disc Medicine, Inc. (IRON) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. Bu biyoteknoloji hissesi i\u00e7in g\u00fcncel fiyat, riskler ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Disc Medicine, Inc. (IRON) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. Bu biyoteknoloji hissesi i\u00e7in g\u00fcncel fiyat, riskler ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"\u0130leri teknoloji biyoteknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Disc Medicine, Inc. (sembol: IRON), hematolojik hastal\u0131k tedavilerinde heyecan verici bir s\u0131n\u0131r\u0131 temsil ediyor. Bu klinik a\u015famadaki biyofarmas\u00f6tik \u015firket, kan hastal\u0131klar\u0131n\u0131n tedavisinde devrim yaratabilir ve erken yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nemli getiriler sa\u011flayabilir. IRON'un neden dikkatinizi hak etti\u011fini ve portf\u00f6y\u00fcn\u00fcz\u00fcn bir par\u00e7as\u0131 haline nas\u0131l getirebilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130leri teknoloji biyoteknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Disc Medicine, Inc. (sembol: IRON), hematolojik hastal\u0131k tedavilerinde heyecan verici bir s\u0131n\u0131r\u0131 temsil ediyor. Bu klinik a\u015famadaki biyofarmas\u00f6tik \u015firket, kan hastal\u0131klar\u0131n\u0131n tedavisinde devrim yaratabilir ve erken yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nemli getiriler sa\u011flayabilir. IRON'un neden dikkatinizi hak etti\u011fini ve portf\u00f6y\u00fcn\u00fcz\u00fcn bir par\u00e7as\u0131 haline nas\u0131l getirebilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Fiyat Analizi<\/h2> <p>29 A\u011fustos 2025 itibar\u0131yla, Disc Medicine, Inc. (IRON) NASDAQ borsas\u0131nda <strong>59,27 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Hisse senedi, Nisan 2025'teki 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesi olan 30,82 $'dan sonra dikkat \u00e7ekici bir <strong>%92 toparlanma<\/strong> g\u00f6sterdi.<\/p> <p><strong>Takviminize not edin: 11 Kas\u0131m 2025<\/strong>, IRON yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in son derece kritik bir tarih. \u015eirketin bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn bu. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olmu\u015ftur\u2014hem yukar\u0131 hem de a\u015fa\u011f\u0131 y\u00f6nl\u00fc.<\/p> <h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3> <p>Son kazan\u00e7 olaylar\u0131na bakmak, neler olabilece\u011fi hakk\u0131nda de\u011ferli bilgiler sunar:<\/p> <p><strong>7 A\u011fustos 2025 (2. \u00c7eyrek Kazan\u00e7lar\u0131)<\/strong>: GAAP net zarar pay ba\u015f\u0131na 1,58 $ olarak raporland\u0131 ve analist beklentilerini 0,41 $ ka\u00e7\u0131rd\u0131ktan sonra hisse yakla\u015f\u0131k %8 d\u00fc\u015ft\u00fc. Ancak, d\u00fc\u015f\u00fc\u015f nispeten k\u0131sa s\u00fcrd\u00fc \u00e7\u00fcnk\u00fc yat\u0131r\u0131mc\u0131lar \u015firketin g\u00fc\u00e7l\u00fc nakit pozisyonu ve yakla\u015fan d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131na odakland\u0131.<\/p> <p><strong>May\u0131s 2025 Kazan\u00e7lar\u0131<\/strong>: 1. \u00e7eyrek raporunun ard\u0131ndan, yat\u0131r\u0131mc\u0131lar \u015firketin NDA sunum zaman \u00e7izelgesindeki ilerlemeyi fark ettik\u00e7e hisse senedi sonraki hafta %12 de\u011fer kazand\u0131.<\/p> <p><strong>\u015eubat 2025<\/strong>: Pozitif klinik deneme g\u00fcncellemeleri, beklenenden daha geni\u015f zararlar\u0131 g\u00f6lgede b\u0131rakarak hisse senedinin %18 y\u00fckselmesine neden oldu.<\/p> <p>Bu desen, kazan\u00e7lara k\u0131sa vadeli tepkilerin dalgal\u0131 olabilece\u011fini, ancak temel klinik ilerlemenin uzun vadeli de\u011fer art\u0131\u015f\u0131n\u0131 y\u00f6nlendirdi\u011fini g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2> <p>Disc Medicine, son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a dalgal\u0131 bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p> <ul> <li><strong>Mart 2025<\/strong>: \u00d6nceki volatilitenin ard\u0131ndan 45-50 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rerek istikrar g\u00f6sterdi<\/li> <li><strong>Nisan 2025<\/strong>: Daha geni\u015f biyoteknoloji sekt\u00f6r\u00fc endi\u015feleri nedeniyle 30,82 $'a (52 haftal\u0131k en d\u00fc\u015f\u00fck) keskin d\u00fc\u015f\u00fc\u015f<\/li> <li><strong>May\u0131s 2025<\/strong>: Kurumsal al\u0131mlar\u0131n artmas\u0131yla 48-52 $ aral\u0131\u011f\u0131nda g\u00fc\u00e7l\u00fc toparlanma<\/li> <li><strong>Haziran 2025<\/strong>: Analist y\u00fckseltmeleriyle desteklenen 58-62 $ aral\u0131\u011f\u0131nda devam eden momentum<\/li> <li><strong>Temmuz 2025<\/strong>: Yat\u0131r\u0131mc\u0131lar\u0131n 2. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 bekledi\u011fi 57-60 $ civar\u0131nda konsolidasyon<\/li> <li><strong>A\u011fustos 2025<\/strong>: Kar\u0131\u015f\u0131k 2. \u00e7eyrek sonu\u00e7lar\u0131na ra\u011fmen 59 $ civar\u0131nda mevcut istikrar<\/li> <\/ul> <p>Genel alt\u0131 ayl\u0131k trend, \u00f6zellikle Nisan ay\u0131ndaki dramatik sat\u0131\u015fa ra\u011fmen <strong>%10,67 art\u0131\u015f<\/strong> g\u00f6steriyor. Toparlanma modeli, g\u00fc\u00e7l\u00fc kurumsal destek ve \u015firketin uzun vadeli beklentilerine olan inanc\u0131 ortaya koyuyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve klinik d\u00f6n\u00fcm noktalar\u0131na dayanarak, bekleyebileceklerimiz \u015funlar:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 75-85 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %26-43 y\u00fckseli\u015f)<br> Ekim ay\u0131nda yap\u0131lacak NDA sunumu b\u00fcy\u00fck bir kataliz\u00f6r olabilir, ayr\u0131ca 4. \u00e7eyrek klinik veri a\u00e7\u0131klamalar\u0131 ek momentum sa\u011flayacakt\u0131r.<\/li> <li><strong>2026 Tahmini<\/strong>: 95-110 $ <br> Ba\u015far\u0131l\u0131 d\u00fczenleyici ilerleme ve bitopertin i\u00e7in ilk ticarile\u015ftirme planlamas\u0131 varsay\u0131larak.<\/li> <li><strong>2028 Projeksiyonu<\/strong>: 130-160 $<br> Birden fazla \u00fcr\u00fcn hatt\u0131n\u0131n tam ticarile\u015ftirilmesi ve yerle\u015fik gelir ak\u0131\u015flar\u0131 potansiyeli.<\/li> <li><strong>2030 Uzun Vadeli Hedef<\/strong>: 180-220 $<br> Olgun \u00fcr\u00fcn portf\u00f6y\u00fc ve ek hematolojik endikasyonlara geni\u015fleme olas\u0131l\u0131\u011f\u0131.<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: Biyoteknoloji volatilitesini tolere edebilen uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: En \u00f6nemli risk\u2014devam eden denemelerden gelecek olumsuz veriler h\u0131zla \u00f6nemli de\u011fer kayb\u0131na yol a\u00e7abilir. \u015eirketin t\u00fcm de\u011feri ba\u015far\u0131l\u0131 ila\u00e7 geli\u015ftirmeye ba\u011fl\u0131d\u0131r.<\/li> <li><strong>D\u00fczenleyici Engeller<\/strong>: FDA onay s\u00fcreci \u00f6ng\u00f6r\u00fclemez. Bitopertin'in NDA's\u0131nda gecikmeler veya reddedilme y\u0131k\u0131c\u0131 olur.<\/li> <li><strong>Mali Yakma H\u0131z\u0131<\/strong>: 2025 2. \u00e7eyrek zararlar\u0131 55,25 milyon $ ile \u015firket h\u0131zla nakit harc\u0131yor. 650 milyon $ nakit rezervi 2028'e kadar runway sa\u011flasa da, gecikmeler seyreltilmi\u015f fonlama gerektirebilir.<\/li> <li><strong>Biyoteknoloji Sekt\u00f6r\u00fc Volatilitesi<\/strong>: IRON, temel de\u011fil duygu odakl\u0131 hareket eden geni\u015f biyoteknoloji sekt\u00f6r\u00fcyle paralel hareket eder.<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Analist Konsens\u00fcs\u00fc<\/strong>: Fiyat hedefleri 132 $'a kadar \u00e7\u0131kan oybirli\u011fiyle \"Al\" tavsiyeleri. BMO Capital Markets (120 $ hedef) ve Morgan Stanley (90 $ hedef) gibi b\u00fcy\u00fck firmalar son derece iyimser.<\/li> <li><strong>Kurumsal Destek<\/strong>: <a href=\"https:\/\/www.defenseworld.net\/2025\/08\/26\/disc-medicine-inc-iron-stock-position-raised-by-charles-schwab-investment-management-inc.html\">Charles Schwab Investment Management, 2025 1. \u00e7eyrekte hisselerini %18 art\u0131rd\u0131<\/a> ve toplam kurumsal sahiplik %83,70 seviyesinde.<\/li> <li><strong>Yakla\u015fan Kataliz\u00f6rler<\/strong>: Ekim 2025 bitopertin NDA sunumu ve 4. \u00e7eyrek klinik veri a\u00e7\u0131klamalar\u0131 birden fazla k\u0131sa vadeli kataliz\u00f6r sunuyor.<\/li> <li><strong>Piyasa Konumu<\/strong>: Hematolojik hastal\u0131klara odaklanarak \u00f6nemli kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lar\u0131 hedefliyor ve s\u0131n\u0131rl\u0131 rekabet var.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazlas\u0131n\u0131 IRON gibi y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine, zamanlama riskini azaltmak i\u00e7in birka\u00e7 hafta boyunca k\u00fc\u00e7\u00fck miktarlarda al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>11 Kas\u0131m \u0130\u00e7in Uyar\u0131 Ayarlay\u0131n<\/strong>: Bir sonraki kazan\u00e7 tarihini i\u015faretleyin ve olas\u0131 volatiliteye haz\u0131rl\u0131kl\u0131 olun<\/li> <li><strong>Klinik G\u00fcncellemeleri Takip Edin<\/strong>: Ekim NDA sunumu b\u00fcy\u00fck bir hareket kataliz\u00f6r\u00fc olabilir<\/li> <\/ol> <p>Esprili bir bak\u0131\u015f: \"IRON ile ticaret yapmak, parlak bir bilim insan\u0131yla ili\u015fki i\u00e7inde olmak gibidir\u2014y\u0131ld\u00f6n\u00fcmlerini (kazan\u00e7 tarihlerini) unutabilirler ama d\u00fcnyay\u0131 (ve portf\u00f6y\u00fcn\u00fcz\u00fc) de\u011fi\u015ftirecek bir \u015fey ke\u015ffedebilirler.\"<\/p> <h2>\u2705 Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve makul komisyon \u00fccretleri sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 A\u00e7\u0131n ve Fonlay\u0131n<\/td><td>Biyoteknoloji volatilitesine kar\u015f\u0131 rahat\u00e7a riske atabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"IRON\" Aramas\u0131 Yap\u0131n<\/td><td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>Sat\u0131n alma i\u015flemini onaylamadan \u00f6nce emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Fiyat Uyar\u0131lar\u0131 Ayarlay\u0131n<\/td><td>52 haftal\u0131k y\u00fcksek seviye 68,73 $ ve destek seviyesi 55 $ gibi \u00f6nemli seviyeleri takip edin<\/td><\/tr> <tr><td>7<\/td><td>\u00c7\u0131k\u0131\u015f Stratejinizi Planlay\u0131n<\/td><td>K\u00e2r alma ve zarar durdurma seviyelerini \u00f6nceden belirleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2> <p>Disc Medicine, Inc. (IRON) hissesine yat\u0131r\u0131m yapmak isteyenler i\u00e7in Pocket Option, giri\u015fin eri\u015filebilir olmas\u0131n\u0131 sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile pozisyonunuzu kademeli olarak olu\u015fturmaya ba\u015flayabilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: KYC s\u00fcreci tek bir belge ile dakikalar i\u00e7inde tamamlan\u0131r<\/li> <li><strong>Esnek Para \u00c7ekme<\/strong>: Kripto paralar ve e-c\u00fczdanlar dahil 100'den fazla para \u00e7ekme y\u00f6ntemi<\/li> <li><strong>Par\u00e7al\u0131 Hisseler<\/strong>: IRON gibi y\u00fcksek fiyatl\u0131 hisselerde pozisyon olu\u015fturmak i\u00e7in m\u00fckemmel<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, biyoteknoloji volatilitesini yeni yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ok daha az korkutucu hale getirir.<\/p> <h2>\ud83c\udf0d 2025'te Disc Medicine: Hematoloji \u0130novasyon Lideri<\/h2> <p>Disc Medicine, heme biyosentezi ve demir homeostaz\u0131 yollar\u0131na odaklanarak ciddi kan hastal\u0131klar\u0131n\u0131n tedavisinde devrim yarat\u0131yor. \u015eirketin \u00fcr\u00fcn hatt\u0131, eritropoietik protoporfiri (EPP), Diamond-Blackfan Anemisi ve miyelofibroz ile ili\u015fkili anemi gibi durumlar i\u00e7in potansiyel olarak \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler i\u00e7eriyor.<\/p> <p><strong>G\u00fcncel Piyasa Konumu<\/strong>: Yakla\u015f\u0131k 2,08 milyar $ piyasa de\u011feri ile Disc Medicine, kurumsal deste\u011fe sahip olacak kadar b\u00fcy\u00fck, ancak klinik programlar\u0131 ba\u015far\u0131l\u0131 olursa \u00f6nemli b\u00fcy\u00fcme potansiyeli sunacak kadar k\u00fc\u00e7\u00fck bir konumda.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Disc Medicine'in ara\u015ft\u0131rmalar\u0131, demir metabolizmas\u0131 ile belirli genetik kan hastal\u0131klar\u0131 aras\u0131nda daha \u00f6nce bilinmeyen bir ba\u011flant\u0131y\u0131 ortaya \u00e7\u0131karmaya yard\u0131mc\u0131 oldu ve bu da d\u00fcnya \u00e7ap\u0131nda milyonlarca hastaya fayda sa\u011flayabilecek tamamen yeni tedavi yakla\u015f\u0131mlar\u0131n\u0131n kap\u0131s\u0131n\u0131 a\u00e7t\u0131.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Fiyat Analizi<\/h2>\n<p>29 A\u011fustos 2025 itibar\u0131yla, Disc Medicine, Inc. (IRON) NASDAQ borsas\u0131nda <strong>59,27 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Hisse senedi, Nisan 2025&#8217;teki 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesi olan 30,82 $&#8217;dan sonra dikkat \u00e7ekici bir <strong>%92 toparlanma<\/strong> g\u00f6sterdi.<\/p>\n<p><strong>Takviminize not edin: 11 Kas\u0131m 2025<\/strong>, IRON yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in son derece kritik bir tarih. \u015eirketin bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn bu. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olmu\u015ftur\u2014hem yukar\u0131 hem de a\u015fa\u011f\u0131 y\u00f6nl\u00fc.<\/p>\n<h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3>\n<p>Son kazan\u00e7 olaylar\u0131na bakmak, neler olabilece\u011fi hakk\u0131nda de\u011ferli bilgiler sunar:<\/p>\n<p><strong>7 A\u011fustos 2025 (2. \u00c7eyrek Kazan\u00e7lar\u0131)<\/strong>: GAAP net zarar pay ba\u015f\u0131na 1,58 $ olarak raporland\u0131 ve analist beklentilerini 0,41 $ ka\u00e7\u0131rd\u0131ktan sonra hisse yakla\u015f\u0131k %8 d\u00fc\u015ft\u00fc. Ancak, d\u00fc\u015f\u00fc\u015f nispeten k\u0131sa s\u00fcrd\u00fc \u00e7\u00fcnk\u00fc yat\u0131r\u0131mc\u0131lar \u015firketin g\u00fc\u00e7l\u00fc nakit pozisyonu ve yakla\u015fan d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131na odakland\u0131.<\/p>\n<p><strong>May\u0131s 2025 Kazan\u00e7lar\u0131<\/strong>: 1. \u00e7eyrek raporunun ard\u0131ndan, yat\u0131r\u0131mc\u0131lar \u015firketin NDA sunum zaman \u00e7izelgesindeki ilerlemeyi fark ettik\u00e7e hisse senedi sonraki hafta %12 de\u011fer kazand\u0131.<\/p>\n<p><strong>\u015eubat 2025<\/strong>: Pozitif klinik deneme g\u00fcncellemeleri, beklenenden daha geni\u015f zararlar\u0131 g\u00f6lgede b\u0131rakarak hisse senedinin %18 y\u00fckselmesine neden oldu.<\/p>\n<p>Bu desen, kazan\u00e7lara k\u0131sa vadeli tepkilerin dalgal\u0131 olabilece\u011fini, ancak temel klinik ilerlemenin uzun vadeli de\u011fer art\u0131\u015f\u0131n\u0131 y\u00f6nlendirdi\u011fini g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2>\n<p>Disc Medicine, son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a dalgal\u0131 bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p>\n<ul>\n<li><strong>Mart 2025<\/strong>: \u00d6nceki volatilitenin ard\u0131ndan 45-50 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rerek istikrar g\u00f6sterdi<\/li>\n<li><strong>Nisan 2025<\/strong>: Daha geni\u015f biyoteknoloji sekt\u00f6r\u00fc endi\u015feleri nedeniyle 30,82 $&#8217;a (52 haftal\u0131k en d\u00fc\u015f\u00fck) keskin d\u00fc\u015f\u00fc\u015f<\/li>\n<li><strong>May\u0131s 2025<\/strong>: Kurumsal al\u0131mlar\u0131n artmas\u0131yla 48-52 $ aral\u0131\u011f\u0131nda g\u00fc\u00e7l\u00fc toparlanma<\/li>\n<li><strong>Haziran 2025<\/strong>: Analist y\u00fckseltmeleriyle desteklenen 58-62 $ aral\u0131\u011f\u0131nda devam eden momentum<\/li>\n<li><strong>Temmuz 2025<\/strong>: Yat\u0131r\u0131mc\u0131lar\u0131n 2. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 bekledi\u011fi 57-60 $ civar\u0131nda konsolidasyon<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: Kar\u0131\u015f\u0131k 2. \u00e7eyrek sonu\u00e7lar\u0131na ra\u011fmen 59 $ civar\u0131nda mevcut istikrar<\/li>\n<\/ul>\n<p>Genel alt\u0131 ayl\u0131k trend, \u00f6zellikle Nisan ay\u0131ndaki dramatik sat\u0131\u015fa ra\u011fmen <strong>%10,67 art\u0131\u015f<\/strong> g\u00f6steriyor. Toparlanma modeli, g\u00fc\u00e7l\u00fc kurumsal destek ve \u015firketin uzun vadeli beklentilerine olan inanc\u0131 ortaya koyuyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve klinik d\u00f6n\u00fcm noktalar\u0131na dayanarak, bekleyebileceklerimiz \u015funlar:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 75-85 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %26-43 y\u00fckseli\u015f)<br \/> Ekim ay\u0131nda yap\u0131lacak NDA sunumu b\u00fcy\u00fck bir kataliz\u00f6r olabilir, ayr\u0131ca 4. \u00e7eyrek klinik veri a\u00e7\u0131klamalar\u0131 ek momentum sa\u011flayacakt\u0131r.<\/li>\n<li><strong>2026 Tahmini<\/strong>: 95-110 $ <br \/> Ba\u015far\u0131l\u0131 d\u00fczenleyici ilerleme ve bitopertin i\u00e7in ilk ticarile\u015ftirme planlamas\u0131 varsay\u0131larak.<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 130-160 $<br \/> Birden fazla \u00fcr\u00fcn hatt\u0131n\u0131n tam ticarile\u015ftirilmesi ve yerle\u015fik gelir ak\u0131\u015flar\u0131 potansiyeli.<\/li>\n<li><strong>2030 Uzun Vadeli Hedef<\/strong>: 180-220 $<br \/> Olgun \u00fcr\u00fcn portf\u00f6y\u00fc ve ek hematolojik endikasyonlara geni\u015fleme olas\u0131l\u0131\u011f\u0131.<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: Biyoteknoloji volatilitesini tolere edebilen uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: En \u00f6nemli risk\u2014devam eden denemelerden gelecek olumsuz veriler h\u0131zla \u00f6nemli de\u011fer kayb\u0131na yol a\u00e7abilir. \u015eirketin t\u00fcm de\u011feri ba\u015far\u0131l\u0131 ila\u00e7 geli\u015ftirmeye ba\u011fl\u0131d\u0131r.<\/li>\n<li><strong>D\u00fczenleyici Engeller<\/strong>: FDA onay s\u00fcreci \u00f6ng\u00f6r\u00fclemez. Bitopertin&#8217;in NDA&#8217;s\u0131nda gecikmeler veya reddedilme y\u0131k\u0131c\u0131 olur.<\/li>\n<li><strong>Mali Yakma H\u0131z\u0131<\/strong>: 2025 2. \u00e7eyrek zararlar\u0131 55,25 milyon $ ile \u015firket h\u0131zla nakit harc\u0131yor. 650 milyon $ nakit rezervi 2028&#8217;e kadar runway sa\u011flasa da, gecikmeler seyreltilmi\u015f fonlama gerektirebilir.<\/li>\n<li><strong>Biyoteknoloji Sekt\u00f6r\u00fc Volatilitesi<\/strong>: IRON, temel de\u011fil duygu odakl\u0131 hareket eden geni\u015f biyoteknoloji sekt\u00f6r\u00fcyle paralel hareket eder.<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Analist Konsens\u00fcs\u00fc<\/strong>: Fiyat hedefleri 132 $&#8217;a kadar \u00e7\u0131kan oybirli\u011fiyle &#8220;Al&#8221; tavsiyeleri. BMO Capital Markets (120 $ hedef) ve Morgan Stanley (90 $ hedef) gibi b\u00fcy\u00fck firmalar son derece iyimser.<\/li>\n<li><strong>Kurumsal Destek<\/strong>: <a href=\"https:\/\/www.defenseworld.net\/2025\/08\/26\/disc-medicine-inc-iron-stock-position-raised-by-charles-schwab-investment-management-inc.html\">Charles Schwab Investment Management, 2025 1. \u00e7eyrekte hisselerini %18 art\u0131rd\u0131<\/a> ve toplam kurumsal sahiplik %83,70 seviyesinde.<\/li>\n<li><strong>Yakla\u015fan Kataliz\u00f6rler<\/strong>: Ekim 2025 bitopertin NDA sunumu ve 4. \u00e7eyrek klinik veri a\u00e7\u0131klamalar\u0131 birden fazla k\u0131sa vadeli kataliz\u00f6r sunuyor.<\/li>\n<li><strong>Piyasa Konumu<\/strong>: Hematolojik hastal\u0131klara odaklanarak \u00f6nemli kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lar\u0131 hedefliyor ve s\u0131n\u0131rl\u0131 rekabet var.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazlas\u0131n\u0131 IRON gibi y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine, zamanlama riskini azaltmak i\u00e7in birka\u00e7 hafta boyunca k\u00fc\u00e7\u00fck miktarlarda al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>11 Kas\u0131m \u0130\u00e7in Uyar\u0131 Ayarlay\u0131n<\/strong>: Bir sonraki kazan\u00e7 tarihini i\u015faretleyin ve olas\u0131 volatiliteye haz\u0131rl\u0131kl\u0131 olun<\/li>\n<li><strong>Klinik G\u00fcncellemeleri Takip Edin<\/strong>: Ekim NDA sunumu b\u00fcy\u00fck bir hareket kataliz\u00f6r\u00fc olabilir<\/li>\n<\/ol>\n<p>Esprili bir bak\u0131\u015f: &#8220;IRON ile ticaret yapmak, parlak bir bilim insan\u0131yla ili\u015fki i\u00e7inde olmak gibidir\u2014y\u0131ld\u00f6n\u00fcmlerini (kazan\u00e7 tarihlerini) unutabilirler ama d\u00fcnyay\u0131 (ve portf\u00f6y\u00fcn\u00fcz\u00fc) de\u011fi\u015ftirecek bir \u015fey ke\u015ffedebilirler.&#8221;<\/p>\n<h2>\u2705 Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul komisyon \u00fccretleri sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 A\u00e7\u0131n ve Fonlay\u0131n<\/td>\n<td>Biyoteknoloji volatilitesine kar\u015f\u0131 rahat\u00e7a riske atabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;IRON&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Sat\u0131n alma i\u015flemini onaylamadan \u00f6nce emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Fiyat Uyar\u0131lar\u0131 Ayarlay\u0131n<\/td>\n<td>52 haftal\u0131k y\u00fcksek seviye 68,73 $ ve destek seviyesi 55 $ gibi \u00f6nemli seviyeleri takip edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u00c7\u0131k\u0131\u015f Stratejinizi Planlay\u0131n<\/td>\n<td>K\u00e2r alma ve zarar durdurma seviyelerini \u00f6nceden belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2>\n<p>Disc Medicine, Inc. (IRON) hissesine yat\u0131r\u0131m yapmak isteyenler i\u00e7in Pocket Option, giri\u015fin eri\u015filebilir olmas\u0131n\u0131 sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile pozisyonunuzu kademeli olarak olu\u015fturmaya ba\u015flayabilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: KYC s\u00fcreci tek bir belge ile dakikalar i\u00e7inde tamamlan\u0131r<\/li>\n<li><strong>Esnek Para \u00c7ekme<\/strong>: Kripto paralar ve e-c\u00fczdanlar dahil 100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/li>\n<li><strong>Par\u00e7al\u0131 Hisseler<\/strong>: IRON gibi y\u00fcksek fiyatl\u0131 hisselerde pozisyon olu\u015fturmak i\u00e7in m\u00fckemmel<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, biyoteknoloji volatilitesini yeni yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ok daha az korkutucu hale getirir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Disc Medicine: Hematoloji \u0130novasyon Lideri<\/h2>\n<p>Disc Medicine, heme biyosentezi ve demir homeostaz\u0131 yollar\u0131na odaklanarak ciddi kan hastal\u0131klar\u0131n\u0131n tedavisinde devrim yarat\u0131yor. \u015eirketin \u00fcr\u00fcn hatt\u0131, eritropoietik protoporfiri (EPP), Diamond-Blackfan Anemisi ve miyelofibroz ile ili\u015fkili anemi gibi durumlar i\u00e7in potansiyel olarak \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler i\u00e7eriyor.<\/p>\n<p><strong>G\u00fcncel Piyasa Konumu<\/strong>: Yakla\u015f\u0131k 2,08 milyar $ piyasa de\u011feri ile Disc Medicine, kurumsal deste\u011fe sahip olacak kadar b\u00fcy\u00fck, ancak klinik programlar\u0131 ba\u015far\u0131l\u0131 olursa \u00f6nemli b\u00fcy\u00fcme potansiyeli sunacak kadar k\u00fc\u00e7\u00fck bir konumda.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Disc Medicine&#8217;in ara\u015ft\u0131rmalar\u0131, demir metabolizmas\u0131 ile belirli genetik kan hastal\u0131klar\u0131 aras\u0131nda daha \u00f6nce bilinmeyen bir ba\u011flant\u0131y\u0131 ortaya \u00e7\u0131karmaya yard\u0131mc\u0131 oldu ve bu da d\u00fcnya \u00e7ap\u0131nda milyonlarca hastaya fayda sa\u011flayabilecek tamamen yeni tedavi yakla\u015f\u0131mlar\u0131n\u0131n kap\u0131s\u0131n\u0131 a\u00e7t\u0131.<\/p>\n"},"faq":[{"question":"Disc Medicine, Inc. (IRON) hisseleri nereden al\u0131nabilir?","answer":"Disc Medicine, Inc. (IRON) hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Disc Medicine, Inc. (IRON) hisselerine yat\u0131r\u0131m yapman\u0131n riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici onay gecikmeleri, y\u00fcksek nakit yakma h\u0131z\u0131 ve biyoteknoloji sekt\u00f6r\u00fcndeki volatilite yer almaktad\u0131r."},{"question":"Disc Medicine, Inc. (IRON) hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analist projeksiyonlar\u0131na g\u00f6re, 2025 sonunda 75-85 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 180-220 $ aras\u0131nda fiyat hedefleri bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayan biri Disc Medicine, Inc. (IRON) hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Yeni ba\u015flayanlar k\u00fc\u00e7\u00fck ba\u015flay\u0131p portf\u00f6ylerinin %3-5'ini ay\u0131rmal\u0131, dolar maliyet ortalamas\u0131 yapmal\u0131, \u00f6nemli tarihleri takip etmeli ve klinik geli\u015fmeleri izlemelidir."},{"question":"Pocket Option platformu Disc Medicine, Inc. (IRON) hisseleri i\u00e7in neden tercih edilir?","answer":"Pocket Option, d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, esnek para \u00e7ekme y\u00f6ntemleri ve par\u00e7al\u0131 hisse al\u0131m imkan\u0131 sunarak yeni yat\u0131r\u0131mc\u0131lar i\u00e7in eri\u015filebilir bir platform sa\u011flar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Disc Medicine, Inc. (IRON) hisseleri nereden al\u0131nabilir?","answer":"Disc Medicine, Inc. (IRON) hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Disc Medicine, Inc. (IRON) hisselerine yat\u0131r\u0131m yapman\u0131n riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici onay gecikmeleri, y\u00fcksek nakit yakma h\u0131z\u0131 ve biyoteknoloji sekt\u00f6r\u00fcndeki volatilite yer almaktad\u0131r."},{"question":"Disc Medicine, Inc. (IRON) hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analist projeksiyonlar\u0131na g\u00f6re, 2025 sonunda 75-85 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 180-220 $ aras\u0131nda fiyat hedefleri bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayan biri Disc Medicine, Inc. (IRON) hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Yeni ba\u015flayanlar k\u00fc\u00e7\u00fck ba\u015flay\u0131p portf\u00f6ylerinin %3-5'ini ay\u0131rmal\u0131, dolar maliyet ortalamas\u0131 yapmal\u0131, \u00f6nemli tarihleri takip etmeli ve klinik geli\u015fmeleri izlemelidir."},{"question":"Pocket Option platformu Disc Medicine, Inc. (IRON) hisseleri i\u00e7in neden tercih edilir?","answer":"Pocket Option, d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, esnek para \u00e7ekme y\u00f6ntemleri ve par\u00e7al\u0131 hisse al\u0131m imkan\u0131 sunarak yeni yat\u0131r\u0131mc\u0131lar i\u00e7in eri\u015filebilir bir platform sa\u011flar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r - Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r - Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T20:49:22+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-29T20:49:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/\",\"name\":\"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r - Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"datePublished\":\"2025-08-29T20:49:22+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r - Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/","og_locale":"tr_TR","og_type":"article","og_title":"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r - Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T20:49:22+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-29T20:49:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/","name":"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r - Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","datePublished":"2025-08-29T20:49:22+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-disc-medicine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Disc Medicine, Inc. (IRON) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Disc Medicine, Inc. (IRON) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":358512,"slug":"how-to-buy-disc-medicine","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Disc Medicine, Inc. (IRON) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Disc Medicine, Inc. (IRON)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-disc-medicine\/"},"pt_AA":{"locale":"pt_AA","id":358507,"slug":"how-to-buy-disc-medicine","post_title":"Como comprar a\u00e7\u00f5es da Disc Medicine, Inc. (IRON) - Investimento em a\u00e7\u00f5es da Disc Medicine, Inc. (IRON)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-disc-medicine\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/358511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=358511"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/358511\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334099"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=358511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=358511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=358511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}